研究单位：[1]Lee's Pharmaceutical Limited[2]Xuanwu Hospital Capital Medical University[3]Nanjing Medical University Beijing,Beijing,China,100053
研究目的：
The main objective of this study is to evaluate the effectiveness and safety of the propionyl-L-carnitine hydrochloride tablets among Chinese population in comparison with the placebo, for treatment of the peripheral arterial diseases (intermittent claudication) with oral supplementation of 2g daily for a 4 months continuous administration.
